1. Early screening of healthy population and tumor-prone population.
By checking whether there are circulating tumor cells in the blood of healthy people, it is suggested to detect the occurrence of tumors early to ensure the early cure rate. People with a family history of cancer, people who are positive for human papillomavirus, people with chronic hepatitis, chronic gastritis and chronic enteritis, people who smoke for a long time, people who are often exposed to toxic and harmful substances, sub-healthy people with heavy life pressure and mental stress, and people with high risk level of tumor susceptibility gene testing are recommended to be tested once every 3 months or half a year.
2. For cancer patients who are being treated, continuous detection is needed to obtain the changing trend of CTC quantity.
(1) The number of CTC has obviously decreased or disappeared, suggesting that patients can benefit from the current treatment, and it is recommended to test it once before each treatment cycle.
(2) (2) The continuous increase or no obvious decrease in the number of CTC indicates that the early treatment effect of patients is not good, or patients are resistant to treatment, and there is a risk of disease deterioration. It is suggested that professional doctors should combine other detection methods to comprehensively evaluate the condition.
3. Monitor the recurrence of tumor patients.
(1) CTC has not been detected, suggesting that the patient's condition is stable or the prognosis is good, and it is recommended to detect it every 3-6 months.
(The detection of CTC suggests that patients have a high risk of tumor recurrence/metastasis, so it is suggested that professional doctors should combine other detection methods to comprehensively evaluate the condition.
If you want to do CTC testing, it is recommended to go to a regular institution, such as Shanghai Meiji Medical Inspection Institute, to ensure the accuracy of the results and avoid being deceived!